Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 1986; Volume 30,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Andersson, T

    1. You have access
      Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

B

  1. Baker, S P

    1. You have access
      Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
      S P Baker and P Posner
      Molecular Pharmacology November 1986, 30 (5) 411-418;

C

  1. Carlson, K E

    1. You have access
      Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;
  2. Collins, A C

    1. You have access
      Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;
  3. Curella, P

    1. You have access
      Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
      A W Tank, L Ham and P Curella
      Molecular Pharmacology November 1986, 30 (5) 486-496;
    2. You have access
      Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents.
      A W Tank, P Curella and L Ham
      Molecular Pharmacology November 1986, 30 (5) 497-503;

D

  1. Dahlgren, C

    1. You have access
      Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;
  2. DeCaprio, A P

    1. You have access
      Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein.
      A P DeCaprio
      Molecular Pharmacology November 1986, 30 (5) 452-458;

E

  1. Entman, M L

    1. You have access
      Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

F

  1. Feldman, R D

    1. You have access
      Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptor.
      R D Feldman, W McArdle and C Lai
      Molecular Pharmacology November 1986, 30 (5) 459-462;

G

  1. Gnegy, M E

    1. You have access
      Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
      C K Mickevicius, J K Harrison and M E Gnegy
      Molecular Pharmacology November 1986, 30 (5) 469-475;

H

  1. Ham, L

    1. You have access
      Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
      A W Tank, L Ham and P Curella
      Molecular Pharmacology November 1986, 30 (5) 486-496;
    2. You have access
      Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents.
      A W Tank, P Curella and L Ham
      Molecular Pharmacology November 1986, 30 (5) 497-503;
  2. Harrison, J K

    1. You have access
      Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
      C K Mickevicius, J K Harrison and M E Gnegy
      Molecular Pharmacology November 1986, 30 (5) 469-475;

L

  1. Lai, C

    1. You have access
      Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptor.
      R D Feldman, W McArdle and C Lai
      Molecular Pharmacology November 1986, 30 (5) 459-462;
  2. Lew, P D

    1. You have access
      Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

M

  1. Manning, D R

    1. You have access
      Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;
  2. Marks, M J

    1. You have access
      Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;
  3. McArdle, W

    1. You have access
      Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptor.
      R D Feldman, W McArdle and C Lai
      Molecular Pharmacology November 1986, 30 (5) 459-462;
  4. Mickevicius, C K

    1. You have access
      Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
      C K Mickevicius, J K Harrison and M E Gnegy
      Molecular Pharmacology November 1986, 30 (5) 469-475;
  5. Mitchell, J R

    1. You have access
      Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;
  6. Mosimann, W

    1. You have access
      Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;

N

  1. Newhouse, M G

    1. You have access
      Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;

P

  1. Paul, S M

    1. You have access
      gamma-Aminobutyric acid (GABA)- and barbiturate-mediated 36Cl- uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel.
      R D Schwartz, P D Suzdak and S M Paul
      Molecular Pharmacology November 1986, 30 (5) 419-426;
  2. Posner, P

    1. You have access
      Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
      S P Baker and P Posner
      Molecular Pharmacology November 1986, 30 (5) 411-418;
  3. Pozzan, T

    1. You have access
      Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;

R

  1. Romm, E

    1. You have access
      Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;

S

  1. Schwartz, R D

    1. You have access
      gamma-Aminobutyric acid (GABA)- and barbiturate-mediated 36Cl- uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel.
      R D Schwartz, P D Suzdak and S M Paul
      Molecular Pharmacology November 1986, 30 (5) 419-426;
  2. Smith, C V

    1. You have access
      Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;
  3. Stendahl, O

    1. You have access
      Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
      T Andersson, C Dahlgren, T Pozzan, O Stendahl and P D Lew
      Molecular Pharmacology November 1986, 30 (5) 437-443;
  4. Stitzel, J A

    1. You have access
      Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;
  5. Suzdak, P D

    1. You have access
      gamma-Aminobutyric acid (GABA)- and barbiturate-mediated 36Cl- uptake in rat brain synaptoneurosomes: evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel.
      R D Schwartz, P D Suzdak and S M Paul
      Molecular Pharmacology November 1986, 30 (5) 419-426;

T

  1. Tachikawa, E

    1. You have access
      Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;
  2. Tank, A W

    1. You have access
      Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;
    2. You have access
      Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
      A W Tank, L Ham and P Curella
      Molecular Pharmacology November 1986, 30 (5) 486-496;
    3. You have access
      Induction of mRNA for tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: evidence for the regulation of tyrosine hydroxylase synthesis by multiple mechanisms in cells exposed to elevated levels of both inducing agents.
      A W Tank, P Curella and L Ham
      Molecular Pharmacology November 1986, 30 (5) 497-503;
  3. Tate, C A

    1. You have access
      Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;
  4. Tsokos-Kuhn, J O

    1. You have access
      Evidence for increased membrane permeability of plasmalemmal vesicles from livers of phenobarbital-induced CCl4-intoxicated rats.
      J O Tsokos-Kuhn, C V Smith, J R Mitchell, C A Tate and M L Entman
      Molecular Pharmacology November 1986, 30 (5) 444-451;

W

  1. Wehner, J M

    1. You have access
      Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
      M J Marks, J A Stitzel, E Romm, J M Wehner and A C Collins
      Molecular Pharmacology November 1986, 30 (5) 427-436;
  2. Weiner, N

    1. You have access
      Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;
  3. Woolkalis, M J

    1. You have access
      Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton.
      K E Carlson, M J Woolkalis, M G Newhouse and D R Manning
      Molecular Pharmacology November 1986, 30 (5) 463-468;

Y

  1. Yanagihara, N

    1. You have access
      Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
      E Tachikawa, A W Tank, N Yanagihara, W Mosimann and N Weiner
      Molecular Pharmacology November 1986, 30 (5) 476-485;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 30, Issue 5
1 Nov 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics